Why real-world data is helping us overcome the shortcomings of traditional clinical trials
Karen Ooms at Quanticate explains why clinical trial data alone is not enough to truly understand a drug’s effectiveness and [...]
Centrists throw wrench in House Democrats’ drug pricing plans
An intraparty fight over drug price controls is threatening to derail Democrats' dreams of sweeping changes to Medicare, Medicaid and [...]
One key study highlights how cancer-drug prices continue to rise in the Us – even if they don’t elsewhere
There is increasing interest in the federal government in lowering prescription drug prices. The US spends more than twice what [...]
BC Platforms To Enable Longitudinal RWD And Genomics Access For Drug Development In Africa – NewsBreak
ZURICH and JOHANNESBURG, Sept. 13, 2021 /PRNewswire/ -- Today, BC Platforms (BCP), a global leader in genomics research, analytics and [...]
Disparities between CEE and EU5 healthcare systems laid bare
Increasing public spending on healthcare in Central and Eastern Europe (CEE) could not only result in healthier populations, it could [...]
Preparing for a post-pandemic world
Janssen’s Mark Hicken, VP of strategy, EMEA, looks at what COVID-19 has taught us and how we can become stronger [...]
White House Unveils Plan to Cut Prescription-Drug Prices
A Biden administration plan to lower prescription-drug prices offers the first detailed road map of administrative actions the White House [...]
Drug maker Cipla has written to National Pharmaceutical Pricing Authority (NPPA), the drug price r..
Drug maker Cipla has written to National Pharmaceutical Pricing Authority (NPPA), the drug price regulator to allow price hike of [...]
The Great Harlot — Major pharmaceutical companies are citing their
As Democrats prepare a massive overhaul of prescription drug policy, major pharmaceutical companies are mounting a lobbying campaign against it, [...]
PhRMA Takes Aim at Medicare Price Negotiation as HHS Digs In
Policies aimed at slowing price growth in the most expensive drug categories could result in slightly fewer drugs coming to [...]
Healthcare CRM Market Worth $17.4 Billion by 2023 – Exclusive Report by MarketsandMarkets™ – Press Release
Pune , India , 2021-Sep-11 — /EPR Network/ — According to the new market research report “Healthcare CRM Market by [...]
As Congress considers drug price reforms, Merck, Lilly and Takeda execs warn of dire consequences
As Congress reconvenes this month to resolve a $3.5 trillion budget package, Democrats are focused on enacting sweeping legislation that [...]
The Art of the Possible Doable
For years, biopharma and healthcare organizations have fantasized about making better use of real-world data. The appeal has long been [...]
PQA-Supported Research Examines Cost Barriers to Medication Access and Adherence
The Pharmacy Quality Alliance (PQA) developed the “ Medication Access Framework for Quality Measurement ” to address the social determinants [...]
How To Diversify Trials: Recruitment Protocols, Other Approaches
How To Diversify Trials: Recruitment Protocols, Other Approaches By Allison Proffitt September 9, 2021 | If you can’t measure it, [...]
What is the Specialty Drug Commercialization Pipeline?
Specialty drugs are high cost pharmaceutical products intended for a small number of patients. The specialty drug commercialization process requires [...]
Recent ISPOR Study Highlights the Use of RWE in Decision-Making
In a recent study published in Value in Health, researchers investigated how real world evidence (RWE) impacted decision-making by the [...]
Biogen CEO Discusses Tumultuous Aduhelm Launch
Biogen CEO Michel Vounatsos recently shared his thoughts regarding the hectic Aduhelm launch at the Morgan Stanley 19th Annual Global [...]
ISPOR Article on Prescription Drug Price Variation in Last Decade
In a recent article published in Value in Health, the authors investigate pharmaceutical drug prices. They note significant variation among payers; [...]
MAPS Webinar Features Authors of Recent MSL Position Statement
The Medical Affairs Professional Society (MAPS) is offering an on-demand webinar featuring insight from the authors of a recently published [...]
Vesto and Oldham Global Collaborate to Offer Financing for High Cost Therapies
Crypto company Vesto and development company Oldham Global have announced a partnership to provide financing for expensive pharmaceuticals. Payers and [...]
Freakonomics, M.D. Podcast on Medical Mysteries Now Available
In the fifth installment of Freakonomics, M.D., Dr. Bapu Jena discusses medical mysteries. He highlights the surprising case of a woman [...]
Harvard Researcher Discusses the Surprising Role of Barbershops in Healthcare
Dr. Bapu Jena highlights the surprising link between barbershops and trust in healthcare. Could barbershops improve health equity? “Bapu Jena [...]
MAPS Podcast on Distinguishing Between Insights and Observations
The Medical Affairs Professional Society (MAPS) is offering a podcast that highlights the differences between insights and observations. Speakers include [...]
Over 15 million U.S. adults under 65 went without medication in 2021 due to high drug costs, study shows
An estimated 15.5 million adults under 65 and 2.3 million seniors were unable to pay for at least one doctor-prescribed [...]